Daniel A. Mapamba

Mbeya, United Republic of Tanzania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Modeling Treatment Response in Tuberculosis Early Bactericidal Activity Trials.

Modeling Treatment Response in Tuberculosis Early Bactericidal Activity Trials.

Journal: CPT: pharmacometrics & systems pharmacology

Published: January 16, 2026

Methods to Improve Confidence in the Accuracy of Molecular Testing for Multidrug-Resistant Tuberculosis.

Methods to Improve Confidence in the Accuracy of Molecular Testing for Multidrug-Resistant Tuberculosis.

Journal: Clinical chemistry

Published: June 13, 2025

panTB-HM: a multi-arm clinical trial of a pan-TB regimen targeting both host and microbe.

panTB-HM: a multi-arm clinical trial of a pan-TB regimen targeting both host and microbe.

Journal: Trials

Published: February 01, 2025

Adjunctive N-Acetylcysteine and Lung Function in Pulmonary Tuberculosis.

Adjunctive N-Acetylcysteine and Lung Function in Pulmonary Tuberculosis.

Journal: NEJM evidence

Published: August 27, 2024

N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis.

N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis.

Journal: The Journal of infection

Published: August 07, 2024

Performance of Tuberculosis Molecular Bacterial Load Assay Compared to Alere TB-LAM in Urine of Pulmonary Tuberculosis Patients with HIV Co-Infections.

Performance of Tuberculosis Molecular Bacterial Load Assay Compared to Alere TB-LAM in Urine of Pulmonary Tuberculosis Patients with HIV Co-Infections.

Journal: International journal of molecular sciences

Published: December 19, 2022

Impact of N-Acetyl Cysteine (NAC) on Tuberculosis (TB) Patients-A Systematic Review.

Impact of N-Acetyl Cysteine (NAC) on Tuberculosis (TB) Patients-A Systematic Review.

Journal: Antioxidants (Basel, Switzerland)

Published: October 04, 2022

Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse.

Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 13, 2021

Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study.

Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study.

Journal: The Journal of infection

Published: April 10, 2018

The impact of repeated NALC/NaOH- decontamination on the performance of Xpert MTB/RIF assay.

The impact of repeated NALC/NaOH- decontamination on the performance of Xpert MTB/RIF assay.

Journal: Tuberculosis (Edinburgh, Scotland)

Published: June 12, 2017

Limited value of whole blood Xpert(®) MTB/RIF for diagnosing tuberculosis in children.

Limited value of whole blood Xpert(®) MTB/RIF for diagnosing tuberculosis in children.

Journal: The Journal of infection

Published: March 09, 2016

Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System.

Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System.

Journal: Journal of clinical microbiology

Published: December 02, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026